KR
Koppisetti Ramesh Chandra
About Koppisetti Ramesh Chandra
Data last updated:
Koppisetti Ramesh Chandra has 9 years in corporate governance. Holds Designated Partner and Director roles. Currently with 1 company, including Cytomol Research And Diagnostic Centre Llp and Hitera Health Care Private Limited. Formerly with 3 companies, such as Drk Avenues Private Limited and Gims Healthcare Llp. Engaged in General Business, Healthcare.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
 Hitera Health Care Private Limited U85300TG2022PTC168157 | Director | 22 May 2024 | 2022 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
| Drk Avenues Private Limited U70109TG2021PTC157580 | Director | 02 Dec 2021 | 2021 | Active |
| Gims Healthcare Llp ABA-7631 | Designated Partner | 19 Sep 2022 | 2022 | Active |
| Designated Partner | 26 Apr 2017 | 2017 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Koppisetti Ramesh Chandra
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Koppisetti Ramesh Chandra
Koppisetti Ramesh Chandra has 9 years in corporate governance. Holds Designated Partner and Director roles. Currently with 1 company, including Cytomol Research And Diagnostic Centre Llp and Hitera Health Care Private Limited. Formerly with 3 companies, such as Drk Avenues Private Limited and Gims Healthcare Llp. Engaged in General Business, Healthcare.
Koppisetti Ramesh Chandra is associated with 1 company as Designated Partner and Director.
Koppisetti Ramesh Chandra has expertise in General Business, Healthcare.
Koppisetti Ramesh Chandra has 9 years in corporate governance.